The Coronary Stent Market in China

Wei Zhang (First Author), Leiping Xu (Participant Author)

Research output: Other contributionCase Studies


Aiming to illustrate an innovation model in an emerging market, this case summarizes the successful launch of drug-eluting stents at MicroPort and the development of innovation capabilities and culture within the company. The case also demonstrates a strategic dilemma appearing after one round of effective technological innovation and, more importantly, how understanding the value system — in this case, the health care system — is key to sustaining innovation.
Original languageEnglish
Number of pages12
Publication statusPublished - 1 Jan 2012

Case number


Case normative number


Case type


Update date


Published by

China Europe International Business School


  • Business model
  • Healthcare
  • Innovation
  • Strategy

Case studies discipline

  • General Management
  • Strategy

Case studies industry

  • Health Care Services


Dive into the research topics of 'The Coronary Stent Market in China'. Together they form a unique fingerprint.

Cite this